Titlebook: Indacaterol; The First Once-daily Alexandre Trifilieff Book 2014 Springer Basel 2014 Asthma.Beta-2-Agonists.Bronchitis.Bronchodilatator.Lun

孵化

書目名稱Indacaterol影響因子(影響力)




書目名稱Indacaterol影響因子(影響力)學(xué)科排名




書目名稱Indacaterol網(wǎng)絡(luò)公開度




書目名稱Indacaterol網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Indacaterol被引頻次




書目名稱Indacaterol被引頻次學(xué)科排名




書目名稱Indacaterol年度引用




書目名稱Indacaterol年度引用學(xué)科排名




書目名稱Indacaterol讀者反饋




書目名稱Indacaterol讀者反饋學(xué)科排名

strdulate

The Early Clinical Development of Indacaterol,elopment of indacaterol confirmed preclinical data characterizing indacaterol as a long-acting β.-agonist with a sustained 24 h duration of bronchodilation, thus suitable for once-daily dosing, a rapid onset of action and a favourable safety profile over a range of dosages and delivery modes, both in asthma and COPD patients of various severities.

洞穴

Current Pharmacotherapy for COPD, a role limited to the severe and very severe patient with frequent exacerbations. Recent evidence suggests that maintenance antibiotic therapy may be additive to the effect of bronchodilators in reducing exacerbation frequency. The choice of agents may be based primarily on individual response, cost, side-effect profile, and availability.

咽下

The Preclinical Pharmacology of Indacaterol,o systems as well as a large cohort of COPD patients, no association could be demonstrated between β.-adrenoceptor polymorphisms and indacaterol response. In conclusion, the preclinical profile of indacaterol suggests that this compound has a duration of action compatible with once-daily dosing in human, together with a fast onset of action.

五行打油詩(shī)

nocturia

2296-6056 cotherapy of COPD.Includes supplementary material: .Chronic obstructive pulmonary disease (COPD) is a multi-component condition that results in increasingly limited airflow, usually associated with an abnormal inflammatory response of the lung. It constitutes a major public health burden worldwide,

Wallow

Indacaterol978-3-0348-0709-8Series ISSN 2296-6056 Series E-ISSN 2296-6064

pulse-pressure

https://doi.org/10.1007/978-3-0348-0709-8Asthma; Beta-2-Agonists; Bronchitis; Bronchodilatator; Lung function

Affiliation

Alexandre TrifilieffSummarizes preclinical and clinical data.A valuable source of information for scientists and clinicians.Contemporary monograph on the pharmacotherapy of COPD.Includes supplementary material:

開始沒(méi)有